[HTML][HTML] Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model

HJ Kwon, SB Han, BR Kim, KR Kang, DH Huh… - BMC infectious …, 2017 - Springer
Background Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during
adolescence was introduced in response to the resurgence of pertussis in various countries …

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17-to 24-month …

DA Blumberg, CAM Mink, JD Cherry… - The Journal of …, 1990 - Elsevier
Healthy 17-to 24-month-old children, previously immunized with three doses of whole-cell
diphtheria-tetanus-pertussis (DTP) vaccine, were enrolled in a multicenter double-blind …

Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants

F Simondon, A Yam, JY Gagnepain, S Wassilak… - European Journal of …, 1996 - Springer
A diphtheria and tetanus toxoid two-component acellular pertussis vaccine (DTaP),
consisting of 25 μg glutaraldehyde-detoxified pertussis toxin (PT) and 25 μg native …

A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults

FM Turnbull, TC Heath, BB Jalaludin, MA Burgess… - Vaccine, 2000 - Elsevier
A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …

Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in …

AE Tozzi, A Anemona, D Stat, P Stefanelli… - …, 2001 - publications.aap.org
Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …

Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers

J Southern, N Andrews, M Burrage, E Miller - Vaccine, 2005 - Elsevier
Sustained high incidence of pertussis, particularly amongst unvaccinated infants, is of
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …

Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age

DI BERNSTEIN, VE SMITH, GM SCHIFF… - The Pediatric …, 1993 - journals.lww.com
The safety and immunogenicity of a booster dose of a new acellular pertussis component
diphtheria-tetanus toxoids-pertussis vaccine (DTaP) were compared with whole cell …

[HTML][HTML] Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

F Martinón-Torres, SA Halperin, T Nolan, B Tapiéro… - Vaccine, 2021 - Elsevier
Background Transplacentally transferred antibodies induced by maternal pertussis
vaccination interfere with infant immune responses to pertussis primary vaccination. We …

Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15-to 24-month-old …

S Feldman, CS Perry, M Andrew, L Jones… - The Journal of …, 1992 - Elsevier
We compared an acellular (B type) pertussis-component diphtheria-tetanuspertussis (DTP-
Ac) vaccine containing equal amounts of filamentous hemagglutinin and lymphocytosis …